| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,895 |
6,572 |
$751K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,805 |
2,507 |
$182K |
| 96158 |
|
874 |
517 |
$41K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,007 |
961 |
$15K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
870 |
826 |
$12K |
| 99205 |
Prolong outpt/office vis |
55 |
55 |
$11K |
| 96159 |
|
489 |
310 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
55 |
54 |
$8K |
| 99408 |
|
133 |
131 |
$4K |
| 96152 |
|
86 |
71 |
$3K |
| 99215 |
Prolong outpt/office vis |
17 |
12 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
914 |
872 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
55 |
53 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
78 |
76 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
14 |
14 |
$2K |
| 90688 |
|
89 |
88 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
31 |
28 |
$1K |
| 96150 |
|
39 |
39 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
31 |
28 |
$1K |
| 96156 |
|
15 |
13 |
$685.98 |
| 90686 |
|
14 |
12 |
$260.54 |